Angiotensin-converting enzyme gene insertion/deletion polymorphism and peripheral arterial occlusive disease

Area of Science:

• Genetics
• Cardiovascular Disease
• Molecular Biology

Background:

• The angiotensin-converting enzyme (ACE) gene deletion polymorphism is associated with increased cardiovascular disease risk.
• This risk is attributed to the sustained activation of the renin-angiotensin system (RAS).
• Peripheral arterial occlusive disease (PAOD) is a significant manifestation of cardiovascular disease.

Purpose of the Study:

• To compare ACE insertion/deletion (I/D) polymorphism frequencies in PAOD patients versus healthy individuals.
• To investigate associations between ACE genotypes and clinical parameters in PAOD patients.

Main Methods:

• Polymerase chain reaction (PCR) was used to determine ACE I/D genotypes.
• Study included 98 PAOD patients (Fontaine stage II) and 240 healthy controls from central Germany.
• Clinical variables (symptom duration, family history, arteriosclerosis score, plasma ACE activity) were correlated with genotypes.

Main Results:

• No significant differences in ACE genotype frequencies were observed between PAOD patients and controls.
• The DD genotype was linked to shorter disease duration (p=0.01), positive family history (p=0.022), and higher plasma ACE activity (p=0.026) compared to the II genotype.
• Arteriosclerosis score (ASF) did not correlate with ACE I/D polymorphism.

Conclusions:

• The study did not find evidence directly linking the ACE deletion allele to PAOD manifestation.
• The ACE deletion allele might have a role in promoting PAOD progression.
• Further research is needed to elucidate the precise role of ACE polymorphism in PAOD.